Literature DB >> 24062266

Fat-soluble antioxidant vitamins, iron overload and chronic malnutrition in β-thalassemia major.

Shuchismita Behera1, Sujata Dixit, Gandham Bulliyya, Shantanu Kumar Kar.   

Abstract

OBJECTIVE: To assess the antioxidant vitamins A (retinol) and E (α-tocopherol) levels, iron status and growth retardation in children with β-thalassemia major in Odisha, an eastern state of India.
METHODS: Forty three children aged 1-15 y diagnosed with β-thalassemia major (28 males and 15 females) and 42 age-matched healthy controls (22 males and 20 females) were studied. β-thalassemia was detected by using Bio-rad variant assay. Measurement of blood hemoglobin (Hb), hematocrit, serum vitamins (A and E) and ferritin was carried out by standard methods.
RESULTS: Mean hemoglobin (6.60 ± 1.84 vs. 11.8 ± 2.29 g/dL, p < 0.01), serum retinol (28.0 ± 17.67 vs. 54.4 ± 36.56 μg/dL, p < 0.001) and α-tocopherol (0.2 ± 0.34 vs. 1.1 ± 0.82 mg/dL, p < 0.001) were significantly lower in children with thalassemia compared with control group, however, serum ferritin (storage iron) was elevated in thalassemia patients (553.7 ± 176.80 vs. 57.3 ± 40.73 ng/mL, p < 0.001). Vitamin E had significantly correlated with hemoglobin and hematocrit values in the patients. Growth retardation in terms of stunting (79 % vs. 24 %, p < 0.0001) and thinness (32.6 % vs. 9.5 %, p < 0.05) was significantly higher in thalassemic children compared with normal children.
CONCLUSIONS: This study shows that children with β-thalas-semia major are in a state of oxidative stress of hyperfer-ritinemia with deprived antioxidant vitamins (A and E) and poor growth status suggesting a possible need for reduction in iron overload and additional antioxidant supplementation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24062266     DOI: 10.1007/s12098-013-1162-0

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  19 in total

1.  Antioxidant status in children with homozygous thalassemia.

Authors:  Veena Dhawan; Kh Ratan Kumar; R K Marwaha; Nirmal K Ganguly
Journal:  Indian Pediatr       Date:  2005-11       Impact factor: 1.411

2.  Effect of excess alpha-hemoglobin chains on cellular and membrane oxidation in model beta-thalassemic erythrocytes.

Authors:  M D Scott; J J van den Berg; T Repka; P Rouyer-Fessard; R P Hebbel; Y Beuzard; B H Lubin
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

Review 3.  Genetic modifiers of beta-thalassemia.

Authors:  Swee Lay Thein
Journal:  Haematologica       Date:  2005-05       Impact factor: 9.941

4.  Increased oxidative stress and iron overload in Jordanian β-thalassemic children.

Authors:  Maher Y Abdalla; Mohammad Fawzi; Salem R Al-Maloul; Nasser El-Banna; Reema F Tayyem; Iman M Ahmad
Journal:  Hemoglobin       Date:  2011       Impact factor: 0.849

5.  Simultaneous determination of retinol and α-tocopherol by high pressure liquid chromatography in micro-volumes of serum.

Authors:  S E Tee; S C Khor
Journal:  Malays J Nutr       Date:  1999-12

6.  Simultaneous determination of alpha-tocopherol and retinol in plasma or red cells by high pressure liquid chromatography.

Authors:  J G Bieri; T J Tolliver; G L Catignani
Journal:  Am J Clin Nutr       Date:  1979-10       Impact factor: 7.045

Review 7.  Growth of children with beta-thalassemia major.

Authors:  Louis Ck Low
Journal:  Indian J Pediatr       Date:  2005-02       Impact factor: 1.967

8.  Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia.

Authors:  Asma Kassab-Chekir; Sandrine Laradi; Selima Ferchichi; Amel Haj Khelil; Moncef Feki; Fathi Amri; Habib Selmi; Mohamed Bejaoui; Abdelhédi Miled
Journal:  Clin Chim Acta       Date:  2003-12       Impact factor: 3.786

9.  Vitamin E and vitamin A concentrations in plasma adjusted for cholesterol and triglycerides by multiple regression.

Authors:  P Jordan; D Brubacher; U Moser; H B Stähelin; K F Gey
Journal:  Clin Chem       Date:  1995-06       Impact factor: 8.327

10.  Iron status and oxidative stress in beta-thalassemia patients in Jakarta.

Authors:  D R Laksmitawati; S Handayani; S K Udyaningsih-Freisleben; V Kurniati; C Adhiyanto; J Hidayat; S Kusnandar; H S D Dillon; B G Munthe; R Wirawan; R R Soegianto; W Ramelan; H J Freisleben
Journal:  Biofactors       Date:  2003       Impact factor: 6.113

View more
  5 in total

1.  Occult HBV infection in multi transfused thalassemia patients.

Authors:  Jyotsna Sabat; Bhagirathi Dwibedi; Leera Dash; Shantanu Kumar Kar
Journal:  Indian J Pediatr       Date:  2014-06-15       Impact factor: 1.967

Review 2.  Vitamin E inadequacy in humans: causes and consequences.

Authors:  Maret G Traber
Journal:  Adv Nutr       Date:  2014-09       Impact factor: 8.701

3.  Nutrition in Thalassemia: A Systematic Review of Deficiency, Relations to Morbidity, and Supplementation Recommendations.

Authors:  Elijah K Goldberg; Ashutosh Lal; Ellen B Fung
Journal:  J Pediatr Hematol Oncol       Date:  2022-01-01       Impact factor: 1.289

4.  Associations of serum retinol, α-tocopherol, and γ-tocopherol with biomarkers among healthy Japanese men.

Authors:  Yu Zou; Da-Hong Wang; Noriko Sakano; Yoshie Sato; Suketaka Iwanaga; Kazuhisa Taketa; Masayuki Kubo; Kei Takemoto; Chie Masatomi; Kiyomi Inoue; Keiki Ogino
Journal:  Int J Environ Res Public Health       Date:  2014-01-30       Impact factor: 3.390

Review 5.  Vitamin and mineral supplementation for β-thalassemia during COVID-19 pandemic.

Authors:  Annette d'Arqom; Melvanda G Putri; Yovani Savitri; Andi Muh Rahul Alfaidin
Journal:  Future Sci OA       Date:  2020-08-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.